The findings in the journal Neuron offer
hope of a treatment that could one day help people who suffer from the
most common forms of blindness, such as macular degeneration and
retinitis pigmentosa.
The chemical is called AAQ and works by
making cells in the retina sensitive to light, said lead researcher
Richard Kramer, University of California Berkeley professor of molecular
and cell biology.
No comments:
Post a Comment